MYC and hepatocellular carcinoma: Additionally, CCDC50 promotes tumor cell proliferation by inhibiting c-Myc ubiquitin-mediated degradation (41) and also contributes to the development of hepatocellular carcinoma through the Ras/Foxo4 signaling pathway (42).